A screening strategy for anti-lung cancer compounds based on metabolic alterations in D-lactate–treated BEAS-2B cells

Published: 5 May 2026| Version 1 | DOI: 10.17632/47dtgxytvm.1
Contributor:
Yinlong Guo

Description

Data from the D-lactate model establishment, as well as from the cell and animal models treated with selenomethionine and berberine.

Files

Categories

Animal

Licence